Mimra Yoshihiro, Ihn Hronobu, Jinnin Masatoshi, Asano Yoshihide, Yamane Kenichi, Yazawa Norihito, Tamaki Kunihiko
Department of Dermatology, Faculty of Medicine, University of Tokyo, Tokyo, Japan.
Int J Dermatol. 2005 Oct;44(10):817-20. doi: 10.1111/j.1365-4632.2005.02584.x.
Anti-agalactosyl immunoglobulin G (IgG) antibodies (anti-AG IgG) have been reported to be detected and correlated with disease activity in some collagen diseases.
Forty-seven serum samples from patients with localized scleroderma were examined using an enzyme-linked immunosorbent assay.
Anti-AG IgG were positive in 19% of patients with localized scleroderma. The frequency of anti-AG IgG in generalized morphea was much higher than that in linear scleroderma or that in morphea. There was a significant correlation between anti-AG IgG levels and the number of the sclerotic lesions and between anti-AG IgG levels and the number of involved areas. The levels of anti-AG IgG were significantly higher in patients with antinuclear antibody, antisingle-stranded DNA antibody or rheumatoid factor than in those without.
Anti-AG IgG can be an indicator of the severity of localized scleroderma.
据报道,在一些胶原病中可检测到抗半乳糖基免疫球蛋白G(IgG)抗体(抗AG IgG),且其与疾病活动相关。
采用酶联免疫吸附测定法检测47例局限性硬皮病患者的血清样本。
19%的局限性硬皮病患者抗AG IgG呈阳性。泛发性硬斑病中抗AG IgG的频率远高于线状硬皮病或硬斑病中的频率。抗AG IgG水平与硬化性病变数量以及与受累区域数量之间存在显著相关性。抗核抗体、抗单链DNA抗体或类风湿因子阳性的患者抗AG IgG水平显著高于无这些抗体的患者。
抗AG IgG可作为局限性硬皮病严重程度的一个指标。